Veronique Lecault - 12 Sep 2023 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Operating Officer, Director
Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
12 Sep 2023
Net transactions value
+$103,800
Form type
4
Filing time
14 Sep 2023, 16:38:44 UTC
Previous filing
09 May 2023
Next filing
16 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $103,800 +20,000 +0.99% $5.19 2,040,122 12 Sep 2023 Direct
holding ABCL Common Shares 273,630 12 Sep 2023 See Footnote F1
holding ABCL Common Shares 7,155,008 12 Sep 2023 See Footnote F2
holding ABCL Common Shares 61,580 12 Sep 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F2 These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.